This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: The promise of serum neurofilament light as a future primary outcome target in clinical trials testing oxaliplatin-induced peripheral neurotoxicity interventions, European Journal of Cancer Care, January 2026, Maximum Academic Press,
DOI: 10.48130/ejcc-0026-0012.
You can read the full text:
The following have contributed to this page
